Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
COUR Pharma Announces Positive One-Year Results from the Phase 2a Study of CNP-104 in Primary Biliary Cholangitis
-
BioCardia Late Breaking Echocardiography Clinical Results from CardiAMP HF Trial Presented at Technology and Heart Failure Therapeutics (THT)
-
Chiesi Global Rare Diseases Announces FDA Approval of JUXTAPID® (lomitapide) Capsules for Pediatric Use in Homozygous Familial Hypercholesterolemia (HoFH)
-
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission
-
Renewal Fuels, Inc. (OTC: RNWF), Operating as American Fusion, Highlights Strategic Imperative for Domestic Fusion Energy as Escalating U.S.–Iran Conflict Raises Energy Security Risks
-
NDT Pharmaceuticals Highlights Enhanced Omni-Channel Positioning; Sets Stage for 2026 Growth with Strategic Marketing Expansion
-
Cirrus Therapeutics Announces Strategic Expansion to Singapore and Other Key Updates Supporting its Growth as a Leading Global Ocular Immunology Company
-
Enphase Energy and Capital Good Fund to Expand IQ Microinverter Deployments for Small Commercial and Residential Projects in the United States
-
Bookipi Survey Shows Small Businesses Embracing AI BUT, Complexity, Not Cost, Slows Workflow Adoption
-
Opus Genetics to Present at Upcoming Investor Conferences in March 2026
-
G2 Recognizes Regula for Advancing Privacy-First Identity Verification
-
Guiding Stars and Partnership for a Healthier America Collaborate to Advance a Nutrition Standard for All
-
LayerX Security Appoints Rupal Hollenbeck as Chair of the Board of Directors
-
Cross Keys Capital Advises SEPA Pain & Spine in Its Partnership with DxTx Pain & Spine
-
Acumen Pharmaceuticals to Showcase Advances in Alzheimer's Treatment at International Conference on Alzheimer’s and Parkinson’s Diseases 2026
-
Prolium Bioscience Launches with $50 Million and Announces First Patients Dosed with PRO-203, a Potential Best-in-Class CD20xCD3 T-Cell Engager, for Severe Autoimmune Disease
-
Fort Wayne Rheumatologists Monica Reddy, Karen Ringwald and Anil Rao Open Fort Wayne Rheumatology and Infusion
-
Prenetics Executives Execute Second Consecutive Round of Post-Earnings Open Market Share Purchases of $1.3 Million— Cumulative Personal Investment Across Both Rounds Reaches $2.7 Million
-
FBS Global Regains Full Nasdaq Compliance; Minimum Bid Price Matter Resolved
-
Kyowa Kirin Announces Discontinuation of Rocatinlimab Clinical Trials
-
Xunlei Limited Announces Entry into Definitive Agreements for Disposition of Majority Equity Interest in Shenzhen Onething
-
Daxor Corporation Reports 2025 Fiscal Year Results: Operating Revenue Up 45%, Net Asset Value Rises to $9.07 Per Share
-
Antelope Enterprise Holdings Limited Announce Reverse Split Record Date
-
KUSTOM ENTERTAINMENT’S DIGITAL ALLY BRAND SECURES MULTI-YEAR BODY CAMERA SUBSCRIPTION WITH PREMIER KANSAS CITY BASED HEALTH SYSTEM
-
Kognitos Bridges the AI Trust Gap with Governed, Deterministic Execution for the Autonomous Enterprise
-
FactSet Integrates Advanced AI Financial Crime Risk Management Tools into Workstation for Corporate Banks
-
Aptera Motors Completes First Vehicle off Validation Assembly Line
-
Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors
-
Village Super Market, Inc. Reports Results for the Second Quarter Ended January 24, 2026
-
ICBA Securities Selects The Baker Group as New Endorsed Provider Following Comprehensive Review
-
Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended December 31, 2025 and Declaration of Distributions on Common Stock for the Months Ending Apri
-
Acumen Pharmaceuticals to Showcase Advances in Alzheimer's Treatment at International Conference on Alzheimer’s and Parkinson’s Diseases 2026
-
Cross Keys Capital Advises SEPA Pain & Spine in Its Partnership with DxTx Pain & Spine
-
National Healthcare Properties Announces $64 million SHOP Acquisition
-
64% of Women Developers Say AI Has Increased Their Career Agency, BairesDev’s Survey Finds
-
Perceptyx Acquires Lyceum AI to Close the Gap Between Employee Experience and Learning and Development
-
Sironix Renewables Launches Furasoft™ – Next Generation, Bio-Based Surfactant for Personal Care
-
Byrna Technologies Announces CEO Transition
-
YETI Holdings, Inc. Announces Participation in Upcoming Investor Conferences
-
Annovis Announces Two Presentations at the AD/PD™ 2026 International Conference
-
Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates
-
Abundia Global Impact Group to Participate in Water Tower Research Fireside Chat on Wednesday, March 4, 2026
-
Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib
-
Upexi to Participate in Upcoming March Investor Conferences
-
PEDEVCO Announces 1-For-20 Reverse Stock Split
-
Arcutis Begins Enrolling Phase 1a/1b Study Evaluating ARQ-234, a CD200R Agonist, in Healthy Volunteers and Adults With Atopic Dermatitis
-
Discuss Introduces Real-Time AI Translation for Observers, Making Global Research Truly Universal
-
Comscore to Announce Fourth Quarter and Full Year 2025 Financial Results
-
Nanox Signs Distribution Agreement with Imperial Imaging Technology to Expand Nanox.ARC Access Across U.S. Southeast
-
Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT
